Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruutu

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Bone Marrow Transplantation|June 15, 2004
Isolated HLA-C mismatches in unrelated donor transplantation for CMLJ-M Tiercy, J Passweg, A van Biezen, et al.
Bone Marrow Transplantation|November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysisT Ruutu, A Gratwohl, D Niederwieser, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
The Finnish leukaemia group: levamisole in maintenance therapy of acute myeloid leukemia in adultsM Lehtinen, P Ahrenberg, A Hänninen, et al.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Lancet (London, England)|May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow TransplantationF Frassoni, M Labopin, R Powles, et al.
Leukemia|July 17, 1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia GroupE Elonen, A Almqvist, A Hänninen, et al.
British Journal of Haematology|September 21, 2000
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)T de Witte, J Hermans, J Vossen, et al.
European Journal of Haematology|February 14, 2004
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycleT Ruutu, E Koivunen, T Nousiainen, et al.
Blood|September 15, 1996
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaJ Jurlander, M A Caligiuri, T Ruutu, et al.
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Bone Marrow Transplantation|June 15, 2004
Isolated HLA-C mismatches in unrelated donor transplantation for CMLJ-M Tiercy, J Passweg, A van Biezen, et al.
Bone Marrow Transplantation|November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysisT Ruutu, A Gratwohl, D Niederwieser, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
The Finnish leukaemia group: levamisole in maintenance therapy of acute myeloid leukemia in adultsM Lehtinen, P Ahrenberg, A Hänninen, et al.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Lancet (London, England)|May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow TransplantationF Frassoni, M Labopin, R Powles, et al.
Leukemia|July 17, 1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia GroupE Elonen, A Almqvist, A Hänninen, et al.
British Journal of Haematology|September 21, 2000
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)T de Witte, J Hermans, J Vossen, et al.
European Journal of Haematology|February 14, 2004
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycleT Ruutu, E Koivunen, T Nousiainen, et al.
Blood|September 15, 1996
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaJ Jurlander, M A Caligiuri, T Ruutu, et al.
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Pageof 23